LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

Authors: Musher, Benjamin L ^*, Rowinsky, Eric K, Smaglo, Brandon G, Abidi, Wasif, Othman, Mohamed, Patel, Kalpesh, Jawaid, Salmaan, Jing, James, Brisco, Amanda, Leen, Ann M, Wu, Mengfen, Sandin, Linda C, Wenthe, Jessica, Eriksson, Emma, Ullenhag, Gustav J, Grilley, Bambi, Leja-Jarblad, Justyna, Hilsenbeck, Susan G, Brenner, Malcolm K, Loskog, Angelica S I

Source: In The Lancet Oncology April 2024 25(4):488-500

Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles

Authors: Broos, Sissela, Sandin, Linda C., Apel, Jenny, Tötterman, Thomas H., Akagi, Takami, Akashi, Mitsuru, Borrebaeck, Carl A.K., Ellmark, Peter, Lindstedt, Malin

Source: In Biomaterials September 2012 33(26):6230-6239

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

Authors: Taylor, Molly A., Hughes, Adina M., Walton, Josephine, Coenen-Stass, Anna M. L., Magiera, Lukasz, Mooney, Lorraine, Bell, Sigourney, Staniszewska, Anna D., Sandin, Linda C., Barry, Simon T., Watkins, Amanda, Carnevalli, Larissa S., Hardaker, Elizabeth L.

Source: Journal for immunotherapy of cancer. 7(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100130994295.0x000001&indx=1&recIds=ETOCvdc_100130994295.0x000001

Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer

Authors: Sandin, Linda C, Tötterman, Thomas H, Mangsbo, Sara M

Source: Oncoimmunology. 3(2)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100050299876.0x000001&indx=1&recIds=ETOCvdc_100050299876.0x000001

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo

Authors: Sandin, Linda C, Eriksson, Fredrik, Ellmark, Peter, Loskog, Angelica SI, Tötterman, Thomas H, Mangsbo, Sara M

Source: Oncoimmunology. 3(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100050299823.0x000001&indx=1&recIds=ETOCvdc_100050299823.0x000001

This result is not displayed to guests.
Login for full access.

Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer.

Authors: Hooren, Luuk, Sandin, Linda C., Moskalev, Igor, Ellmark, Peter, Dimberg, Anna, Black, Peter, Tötterman, Thomas H., Mangsbo, Sara M.

Source: European Journal of Immunology; Feb2017, Vol. 47 Issue 2, p385-393, 9p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.